WPI 845 (Glipizide Extended Release 10 mg)
Pill with imprint WPI 845 is White, Round and has been identified as Glipizide Extended Release 10 mg. It is supplied by Watson Laboratories, Inc..
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 845
- WPI 845
- 10 mg
- 6.00 mm
- Prescription only
- Drug Class
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Laboratories, Inc.
- Inactive Ingredients
acetyltributyl citrate, ammonia, butyl alcohol, ferrosoferric oxide, hydroxyethyl cellulose (2000 cps at 1%), isopropyl alcohol, lactose monohydrate, magnesium stearate, methacrylic acid - methyl methacrylate copolymer (1:1), polyethylene glycol 400, propylene glycol, shellac
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|00591-0845||Watson Pharmaceuticals, Inc.|
|68084-0112||Amerisource Health Services|
|10370-0191||Anchen Pharmaceuticals, Inc.|
|54569-5548||A-S Medication Solutions, LLC (repackager)|
|54868-4988||Physicians Total Care Inc. (repackager)|
|55289-0301||PDRX Pharmaceuticals Inc. (repackager)|
Related Images for "WPI 845"
More about glipizide
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 59 Reviews
- Drug class: sulfonylureas
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.